NCT/Study#

NL-201-MM

Phase 1 IV-infusion study of our investigational drug, NL-201

Phase 1 IV-infusion study of our investigational drug, NL-201

DISEASE GROUP:
Multiple Myeloma
current phase:
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: